Surgical removal of visceral adipose tissue: Effects on insulin action

Current Diabetes Reports

Volumn 3, Issue 3, 2003, Pages 201-206

  Gabriely, Ilan ^b   Barzilai, Nir ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; LEPTIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; BODY FAT; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RAT; REVIEW; ANIMAL; BLOOD; PHYSIOLOGY; SKIN; VISCERA;

ADIPOSE TISSUE; ANIMALS; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MODELS, ANIMAL; OBESITY; RATS; SKIN; VISCERA;

EID: 0042521201     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-003-0064-3     Document Type: Review

References (31)

1. Peiris AN, Struve MF, Mueller RA, et al.: Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab 1988, 67:760-767.
2. Carey DG, Jenkins AB, Campbell LV, et al.: Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996, 45:633-638.
3. O'Shaughnessy IM, Myers TJ, Stepniakowski K, et al.: Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 1995, 26:186-192.
4. Bjorntorp P: "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990, 10:493-496.
5. Argaud D, Zhang Q, Pan W, et al.: Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5′-flanking sequence. Diabetes 1996, 45:1563-1571.
6. Gabbay RA, Sutherland C, Gnudi L, et al.: Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase. J Biol Chem 1996, 271:1890-1897.
7. O'Brien RM, Noisin EL, Suwanichkul A, et al.: Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol 1995, 15:1747-1758.
8. Barzilai N, Banerjee S, Hawkins M, et al.: Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 1998, 101:1353-1361.
9. Barzilai N, Hawkins M, Massilon D, et al.: Leptin selectively decreases visceral adiposity and enhances peripheral and hepatic insulin action. J Clin Invest 1997, 100:3105-3110.
10. Barzilai N, She L, Liu BQ, et al.: Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999, 48:94-98.
11. Barzilai N, Gabriely I: The role of fat depletion in the biological benefits of caloric restriction. J Nutr 2001, 131:903S-906S.
12. Masoro EJ: Possible mechanisms underlying the antiaging actions of caloric restriction. Toxicol Pathol 1996, 24:738-741.
13. Masoro EJ: Caloric restriction and aging: an update. Exp Gerontol 2000, 35:299-305.
14. Weindruch R: The retardation of aging by caloric restriction: studies in rodents and primates. Toxicol Pathol 1996, 24:742-745
15. Gabriely I, Ma XH, Yang XM, et al.: Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002, 51:2951-2958.
16. Wagner R, Oberste-Berghaus C, Herpertz S, et al.: Time relationship between circadian variation of serum levels of leptin, insulin and cortisol in healthy subjects. Horm Res 2000, 54:174-180.
17. Rossetti L, Hawkins M, Chen W, et al.: In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 1995, 96:132-140.
18. Wang J, Liu R, Hawkins M, et al.: A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998, 393:684-688.
19. Gabriely I, Yang XM, Cases JA, et al.: Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway. Atherosclerosis 2002, 160:115-122.
20. Barzilai N, Gupta G: Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution. Ann N Y Acad Sci 1999, 892:58-72.
21. Wang J, Liu R, Liu L, et al.: The effect of leptin on Lep expression is tissue-specific and nutritionally regulated. Nat Med 1999, 5:895-899.
22. Hotamisligil GS, Budavari A, Murray D, et al.: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994, 94:1543-1549.
23. Kanety H, Feinstein R, Papa MZ, et al.: Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 1995, 270:23780-23784.
24. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
25. Uysal KT, Wiesbrock SM, Marino MW, et al.: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
26. Hotamisligil GS, Arner P, Caro JF, et al.: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415.
27. Hofmann C, Lorenz K, Braithwaite SS, et al.: Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994, 134:264-270.
28. Scherer PE, Williams S, Fogliano M, et al.: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
29. Gabriely I, Yang XM, Cases JA, et al.: Hyperglycemia modulates angiotensinogen gene expression. Am J Physiol 2001, 281:R795-R802.
30. Steppan CM, Bailey ST, Bhat S, et al.: The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
31. Combs TP, Berg AH, Obici S, et al.: Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001, 108:1875-1881.